SE8205313L - Antigen-proteinkomplex for blockering av allergiska reaktioner samt sett for framstellning derav - Google Patents
Antigen-proteinkomplex for blockering av allergiska reaktioner samt sett for framstellning deravInfo
- Publication number
- SE8205313L SE8205313L SE8205313A SE8205313A SE8205313L SE 8205313 L SE8205313 L SE 8205313L SE 8205313 A SE8205313 A SE 8205313A SE 8205313 A SE8205313 A SE 8205313A SE 8205313 L SE8205313 L SE 8205313L
- Authority
- SE
- Sweden
- Prior art keywords
- antigen
- allergic reactions
- preparation
- kitchen
- protein complex
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/07—Benzo[b]pyran-4-ones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/805—Drug, bio-affecting and body treating compositions involving IgE or IgD
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Claims (1)
1. Analogiforfarande for framstdllning av ett antigen-proteinkomplex, lampligt for blockering av allergiska reaktioner mot tii2otej, vilket komplex Oar strukturen OH " OH glutamyl-cystein-glycin (giutationl eventuellt hundet till Ott protein eller en peptid via en peptidhindningiglutationsenheten,kannetocknat av att quercitin omsdttes med glutation under oxidations-additions-betingelser varefter karboxylgrupperna i den sd erhdllna produkten eventuellt aktiveras act konjugeras med ett protein eller en peptid via glntaminsyra- oiler glycindelen i glutationsdelen.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/731,414 US4140679A (en) | 1976-10-12 | 1976-10-12 | Antigen-protein complex for blocking allergic reactions |
Publications (2)
Publication Number | Publication Date |
---|---|
SE8205313L true SE8205313L (sv) | 1982-09-16 |
SE8205313D0 SE8205313D0 (sv) | 1982-09-16 |
Family
ID=24939399
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7711422A SE427419B (sv) | 1976-10-12 | 1977-10-11 | Analogiforfarande for framstellning av ett antigent komplex for blockering av allergiska reaktioner mot grespollenantigen |
SE8205313A SE8205313D0 (sv) | 1976-10-12 | 1982-09-16 | Antigen-proteinkomplex for blockering av allergiska reaktioner samt sett for framstellning derav |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7711422A SE427419B (sv) | 1976-10-12 | 1977-10-11 | Analogiforfarande for framstellning av ett antigent komplex for blockering av allergiska reaktioner mot grespollenantigen |
Country Status (17)
Country | Link |
---|---|
US (2) | US4140679A (sv) |
JP (1) | JPS5347516A (sv) |
AU (1) | AU510639B2 (sv) |
BE (1) | BE859620A (sv) |
CA (1) | CA1099258A (sv) |
CH (1) | CH636524A5 (sv) |
DE (1) | DE2744983A1 (sv) |
DK (1) | DK448677A (sv) |
ES (1) | ES463124A1 (sv) |
FI (1) | FI58501C (sv) |
FR (2) | FR2382458A1 (sv) |
GB (2) | GB1552057A (sv) |
LU (1) | LU78273A1 (sv) |
NL (1) | NL7711026A (sv) |
NO (2) | NO147860C (sv) |
SE (2) | SE427419B (sv) |
ZA (1) | ZA775742B (sv) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4256732A (en) * | 1978-08-15 | 1981-03-17 | Research Corporation | Modified grass pollen antigens |
US4220565A (en) * | 1979-01-18 | 1980-09-02 | Scripps Clinic & Research Foundation | Immunochemical conjugates: method and composition |
JPS5639022A (en) * | 1979-09-05 | 1981-04-14 | Hayashibara Biochem Lab Inc | Preparation of vaccine |
WO1981001145A1 (en) * | 1979-10-18 | 1981-04-30 | Univ Illinois | Hydrolytic enzyme-activatible pro-drugs |
US4469677A (en) * | 1980-02-19 | 1984-09-04 | Michael J Gabriel | Polypeptide active immunosuppressant fraction |
GB2097647B (en) * | 1980-10-08 | 1985-07-03 | Cornell Res Foundation Inc | Lower allergenicity and lower thrombogenicity foodstuff and process for preparing the same |
FR2502786B1 (fr) * | 1981-03-24 | 1985-06-21 | Stallergenes Laboratoire | Procede de fixation d'antigenes et d'anticorps sur support de polysaccharides, et utilisation du produit ainsi obtenu pour les dosages immunologiques |
US6022544A (en) | 1983-01-24 | 2000-02-08 | The John Hopkins University | Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
US5370871A (en) * | 1983-01-24 | 1994-12-06 | The Johns Hopkins University | Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
US5126131A (en) * | 1983-01-24 | 1992-06-30 | The Johns Hopkins University | Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates. |
SE8303401D0 (sv) * | 1983-06-15 | 1983-06-15 | Pharmacia Ab | Beredning och dess anvendning |
US4702907A (en) * | 1983-08-09 | 1987-10-27 | Cornell Research Foundation, Inc. | Process for inducing selective immunosuppression of antibodies |
US5447722A (en) * | 1983-12-12 | 1995-09-05 | University Of Manitoba | Method for the suppression of an immune response with antigen-MPEG conjugates in nonsensitized individuals |
US4880635B1 (en) * | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
US4740371A (en) * | 1984-09-17 | 1988-04-26 | International Institute Of Cellular And Molecular Pathology | Treatment of allergy |
US5026545A (en) * | 1984-09-17 | 1991-06-25 | Baxter International, Inc. | Treatment of allergy and composition therefor |
US5543145A (en) * | 1984-09-17 | 1996-08-06 | Baxter International, Inc. | Pharmaceutical composition and method for the suppression of factor VIII inhibitor production |
US4946945A (en) * | 1987-06-23 | 1990-08-07 | Allergy Immuno Technologies, Inc. | Immunotherapy agents for treatment of IgE mediated allergies |
US5116612A (en) * | 1987-06-23 | 1992-05-26 | Allergy Immuno Technologies, Inc. | Immunotherapy agents for treatment of IgE mediated allergies |
US4990336A (en) * | 1989-02-08 | 1991-02-05 | Biosearch, Inc. | Sustained release dosage form |
CA2015515C (en) | 1990-01-03 | 1999-12-07 | Jean-Marie Saint-Remy | Pharmaceutical compositions containing antigen-antibody complexes and uses therefor |
US5126147A (en) * | 1990-02-08 | 1992-06-30 | Biosearch, Inc. | Sustained release dosage form |
US5191066A (en) * | 1990-12-07 | 1993-03-02 | Abbott Laboratories | Site-specific conjugation of immunoglobulins and detectable labels |
US5948443A (en) * | 1996-02-23 | 1999-09-07 | Medical Doctor's Research Institute, Inc. | Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease |
US5976568A (en) * | 1997-02-21 | 1999-11-02 | Medical Doctors' Research Institute, Inc. | Modular system of dietary supplement compositions for optimizing health benefits and methods |
US6656488B2 (en) * | 2001-04-11 | 2003-12-02 | Ethicon Endo-Surgery, Inc. | Bioabsorbable bag containing bioabsorbable materials of different bioabsorption rates for tissue engineering |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO132132C (sv) * | 1968-10-10 | 1975-09-24 | David George Marsh | |
GB1282163A (en) * | 1969-08-06 | 1972-07-19 | Beecham Group Ltd | Modified allergens and a process for their preparation |
GB1578348A (en) * | 1976-08-17 | 1980-11-05 | Pharmacia Ab | Products and a method for the therapeutic suppression of reaginic antibodies responsible for common allergic |
-
1976
- 1976-10-12 US US05/731,414 patent/US4140679A/en not_active Expired - Lifetime
-
1977
- 1977-09-26 ZA ZA00775742A patent/ZA775742B/xx unknown
- 1977-09-27 AU AU29158/77A patent/AU510639B2/en not_active Expired
- 1977-10-06 FI FI772945A patent/FI58501C/fi not_active IP Right Cessation
- 1977-10-06 DE DE19772744983 patent/DE2744983A1/de not_active Withdrawn
- 1977-10-07 NL NL7711026A patent/NL7711026A/xx not_active Application Discontinuation
- 1977-10-07 CA CA288,312A patent/CA1099258A/en not_active Expired
- 1977-10-10 LU LU78273A patent/LU78273A1/xx unknown
- 1977-10-10 GB GB46106/78A patent/GB1552057A/en not_active Expired
- 1977-10-10 DK DK448677A patent/DK448677A/da not_active Application Discontinuation
- 1977-10-10 GB GB42048/77A patent/GB1552056A/en not_active Expired
- 1977-10-11 NO NO773465A patent/NO147860C/no unknown
- 1977-10-11 SE SE7711422A patent/SE427419B/sv unknown
- 1977-10-11 CH CH1237477A patent/CH636524A5/fr not_active IP Right Cessation
- 1977-10-11 FR FR7730521A patent/FR2382458A1/fr active Granted
- 1977-10-11 ES ES463124A patent/ES463124A1/es not_active Expired
- 1977-10-12 JP JP12290977A patent/JPS5347516A/ja active Pending
- 1977-10-12 BE BE181650A patent/BE859620A/xx unknown
-
1978
- 1978-06-09 FR FR7817302A patent/FR2382460A1/fr active Granted
- 1978-07-05 US US05/922,222 patent/US4158705A/en not_active Expired - Lifetime
-
1982
- 1982-08-20 NO NO822838A patent/NO822838L/no unknown
- 1982-09-16 SE SE8205313A patent/SE8205313D0/sv not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
SE7711422L (sv) | 1978-04-13 |
GB1552057A (en) | 1979-09-05 |
FR2382458B1 (sv) | 1982-11-19 |
DE2744983A1 (de) | 1978-04-13 |
BE859620A (fr) | 1978-02-01 |
FI772945A (fi) | 1978-04-13 |
NO147860B (no) | 1983-03-21 |
NO822838L (no) | 1978-04-13 |
FI58501C (fi) | 1981-02-10 |
FR2382460A1 (fr) | 1978-09-29 |
CH636524A5 (fr) | 1983-06-15 |
SE427419B (sv) | 1983-04-11 |
DK448677A (da) | 1978-04-13 |
ES463124A1 (es) | 1978-07-01 |
JPS5347516A (en) | 1978-04-28 |
NO773465L (no) | 1978-04-13 |
AU510639B2 (en) | 1980-07-03 |
GB1552056A (en) | 1979-09-05 |
US4140679A (en) | 1979-02-20 |
US4158705A (en) | 1979-06-19 |
SE8205313D0 (sv) | 1982-09-16 |
FR2382458A1 (fr) | 1978-09-29 |
LU78273A1 (sv) | 1978-01-23 |
AU2915877A (en) | 1979-04-05 |
CA1099258A (en) | 1981-04-14 |
FI58501B (fi) | 1980-10-31 |
FR2382460B1 (sv) | 1982-11-19 |
ZA775742B (en) | 1978-08-30 |
NL7711026A (nl) | 1978-04-14 |
NO147860C (no) | 1983-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8205313L (sv) | Antigen-proteinkomplex for blockering av allergiska reaktioner samt sett for framstellning derav | |
KR900009095A (ko) | 합성 항원, 이의 제조방법 및 용도 | |
EP0284587A3 (en) | Synthetic peptide antigens for the detection of hiv-1 infection | |
DE3588203T2 (de) | Durch pre-S-Gen kodierte Hepatitis-B-Peptid-Immunogene, Vakzine, Diagnostika und synthetische Lipid-Bläschenträger | |
JPS5781447A (en) | Human chorionic gonadotropic hormone c-terminal fragment | |
NO175482C (no) | Peptidblanding for in vitro påvisning av antistoffer mot HTLV-III, anvendelse derav og prövesett for denne | |
CA2078694A1 (en) | Hepatitis b vaccine | |
EP0243913A3 (en) | Pre-s gene codes peptide hepatitis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers | |
NO166466C (no) | Fremgangsmaate for detektering eller bestemmelse av et peptid inneholdende en antigenisk aktiv sekvens av aminosyrer. | |
KR900700507A (ko) | Htlv-1 감염 검출용 합성 펩티드 항원 | |
CA2129747A1 (en) | Peptide for diagnosing and immunizing against t. cruzi infection | |
Schams et al. | Chemical and immunochemical studies on pregnant mare serum gonadotropin | |
Gitlin et al. | A comparison of the peptides released from related rabbit antibodies by enzymatic hydrolysis | |
JPS5657753A (en) | Novel glucagon fragment, and its use | |
SE8902148L (sv) | Syntetiska peptid antigen foer detektion av htlv-1 infektion | |
ATE116660T1 (de) | Künstliche peptid-zusammensetzungen mit immunoreaktiven antikörpern von htlv-1. | |
EP0177814A3 (en) | Peptide antibodies and their use in detecting oncogene products | |
Kelly et al. | Immunological studies on the major haptenic peptides from performic acid oxidized ferredoxin from Clostridium pasteurianum | |
WO1993017108A3 (fr) | Peptides analogues de l'image interne d'une proteine virale | |
AU3455693A (en) | Peptides of the casein macropeptide, antibodies directed against said peptides, and applications | |
EP0237252A3 (en) | Methods and compositions relating to regression-associated antigens | |
NO881661L (no) | Humane rhinoviruspeptider. | |
PT91397A (pt) | Processo de preparacao de polipeptideos sinteticos e de anticorpos relacionados com o antigenio nuclear do virus de epstein-barr | |
SE8605513D0 (sv) | Ny peptid och immunologiskt aktiva foreningar | |
JPS5599072A (en) | Production of artificial antigen containing choline residue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |
Ref document number: 8205313-3 Format of ref document f/p: F |